FDA has received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products.
Read More
A Michigan company is suing a telepharmacy that allegedly supplied fake Ozempic. New resources about the risks of compounded medicines. Details about the fake cancer drug ring busted in India.
Read More
New information on the patients recently hurt by counterfeit Botox, two news stories involving pill presses, and a prosecution announced in Austria over fake Ozempic that sent multiple people to the hospital.
Read More
The Cooper Davis and Devin Norring Act would force social media to report online drug sales. Additional news involves counterfeit cancer drugs sold in the U.S., fake cosmetic injections and more.
Read More
Adam Brosius, Patrick Boyd and Charles Boyd are facing eight counts for selling $90 million of diverted prescription drugs from five black-market suppliers.
Read More
On June 13, 2024, PSM sent a letter to Congressmen Darrell Issa and Jerrold Nadler applauding the reintroduction of the Stopping Harmful Offers on Platforms by Screening Against Fake E-Commerce (SHOP SAFE) Act.
Read More
Fake Ozempic has been found in Brazil, the U.K., and the U.S. Eli Lilly warned the public about fake and compounded tirzepatide medicines. Additional domestic and international stories.
Read More
Florida still has not imported a single pill, patients seeking GLP-1 medicines at increased risk from phishing scams, the counterfeit medicine news from three other countries.
Read More
“Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products”
Read More
The FDA published its annual drug shortage report for 2023, CBP in Cincinnati seized multiple shipments of fake Ozempic, and international counterfeit medicine stories out of six different countries.
Read More